Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis ...

U.S. to Cover PrEP for Older Americans to Stem the Spread of HIV — Biden administration hopes to catch up with other parts of the world by Michael Scaturro, KFF Health News November 12, 2023 ...

For some people, HIV feels like something that happens to “other people.” It’s a distant issue — something for a different ...

HIV prevention pills should be free, but insurers are still charging. ... Public health experts credit PrEP for declines in new HIV infections, about 32,000 in 2022. The treatment, ...

PrEP, a Key HIV Prevention Tool, isn’t reaching Black women. New HIV infections occur disproportionately among Black women, ... “Soon people demanded it for free on the NHS. ...

The first study to characterize use of pre-exposure prophylaxis (PrEP) for HIV prevention in veterans urges efforts that focus on "moderate-to-high HIV prevalence regions and standardization of ...

The finances behind preventing HIV and AIDS. The prices for HIV-prevention medication PrEP can range from 50 cents a day to north of $18,000 annually.

PrEP. Pre-exposure prophylaxis.A daily (sometimes monthly or tri-monthly) medication that prevents HIV for all people. PrEP is not a cocktail that gay men throw back at the bar - it is a ...

New preliminary data from the Centers for Disease Control and Prevention (CDC) indicates more than a third of people who could benefit from preexposure prophylaxis (PrEP) for HIV received a ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes Zandraetta Tims-Cook, MD, MPH, AAHIVS In the US, we have made remarkable ...

For decades, HIV prevention relied on daily pills, but science has made incredible strides. The drug Lenacapavir, originally used for HIV treatment, has been shown to work as PrEP.